Literature DB >> 8927019

Blindness caused by diabetes--Massachusetts, 1987-1994.

.   

Abstract

Diabetes, the leading cause of new blindness among U.S. adults aged 20-74 years, accounts for approximately 8% of cases of legal blindness and 12% of all new cases of blindness in the United States each year. One of the national health objectives for the year 2000 is to decrease by 50% the incidence of blindness caused by diabetes (objective 17.10). However, surveillance for blindness among persons with diabetes has not been conducted nationally, and national prevalence estimates of blindness caused by diabetes have been based on state data from the register of the Massachusetts Commission for the Blind (MCB). To characterize recent trends, data on legal blindness caused by diabetes among adults with diabetes in Massachusetts were examined for 1987-1994. This report summarizes the results of that analysis, which indicate that in Massachusetts, the overall incidence and prevalence of legal blindness caused by diabetes did not decrease, despite the availability of methods to prevent vision loss.

Entities:  

Mesh:

Year:  1996        PMID: 8927019

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  15 in total

1.  [Cataract surgery. Effect on the posterior segment of the eye].

Authors:  W A Herrmann; H Heimann; H Helbig
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

2.  Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2.

Authors:  Irini P Chatziralli; Theodoros N Sergentanis; Petros Keryttopoulos; Nikolaos Vatkalis; Antonis Agorastos; Leonidas Papazisis
Journal:  BMC Res Notes       Date:  2010-06-01

3.  Nerve growth factor in diabetic retinopathy: beyond neurons.

Authors:  Barbara A Mysona; Ahmed Y Shanab; Sally L Elshaer; Azza B El-Remessy
Journal:  Expert Rev Ophthalmol       Date:  2014-04

Review 4.  Intravitreal steroid versus macular laser for treatment of diabetic macular edema.

Authors:  Jonathan Gunther; Michael Ip
Journal:  Curr Diab Rep       Date:  2009-08       Impact factor: 4.810

5.  Oscillation of angiogenesis with vascular dropout in diabetic retinopathy by VESsel GENeration analysis (VESGEN).

Authors:  Patricia Parsons-Wingerter; Krishnan Radhakrishnan; Mary B Vickerman; Peter K Kaiser
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

6.  Mechanisms Underlying Early-Stage Changes in Visual Performance and Retina Function After Experimental Induction of Sustained Dyslipidemia.

Authors:  Christa L Montgomery; Heather M Johnson; Thomas P Johnston; Peter Koulen
Journal:  Neurochem Res       Date:  2018-06-02       Impact factor: 3.996

7.  Endothelin receptor-A antagonist attenuates retinal vascular and neuroretinal pathology in diabetic mice.

Authors:  Jonathan C Chou; Stuart D Rollins; Minghao Ye; Daniel Batlle; Amani A Fawzi
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

Review 8.  Intravitreal steroids for macular edema in diabetes.

Authors:  D Grover; T J Li; C C W Chong
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

9.  Retinopathy and risk factors in diabetic patients from Al-Madinah Al-Munawarah in the Kingdom of Saudi Arabia.

Authors:  Mohamed F El-Bab; Nashaat Shawky; Ali Al-Sisi; Mohamed Akhtar
Journal:  Clin Ophthalmol       Date:  2012-02-17

10.  Design and Development of a Mobile-Based Self-Care Application for Patients with Type 2 Diabetes.

Authors:  Esmaeil Mehraeen; Mohammad Mehrtak; Nazanin Janfaza; Amirali Karimi; Mohammad Heydari; Pegah Mirzapour; Adele Mehranfar
Journal:  J Diabetes Sci Technol       Date:  2021-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.